High levels of IL-6 and IL-10 could be useful biomarkers to discriminate non-COVID-19 pneumonia from COVID-19 pneumonia, which is in line with other reports where the IL-6 and IL-10 ratio has been suggested as a useful biomarker to discriminate severe pneumonia cases at admission [45]. Here, IL10 is linked to susceptibility to pneumonia measurement.